A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma

Published:2018-03-13 Issue:12 Volume:24 Page:2740-2748
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Méndez Eduardo,Rodriguez Cristina P.,Kao Michael C.,Raju Sharat,Diab Ahmed,Harbison R. Alex,Konnick Eric Q.^ORCID,Mugundu Ganesh M.,Santana-Davila Rafael,Martins Renato,Futran Neal D.,Chow Laura Q.M.

Funder

HHS | NIH | National Cancer Institute (NCI)

American Cancer Society (ACS)

HHS | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD)

AstraZeneca

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1;Cancer Cell International;2024-09-13

2. AZD1775 synergizes with SLC7A11 inhibition to promote ferroptosis;Science China Life Sciences;2024-09-06

3. Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy;Phytomedicine;2024-06

4. Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethality;Science Bulletin;2024-05

5. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer;International Journal of Molecular Sciences;2024-04-03